About Avyantra
Avyantra is a Healthcare company based in Hyderabad (India) founded in 2017 by Hyma Goparaju and Kalluri Venkata Narasimha Rao. Developer of ML technology for neonatal diseases and automated peritoneal dialysis device. Its chief executive, as recorded, is Hyma Goparaju. Its Indian entity Avyantra Health Technologies Private Limited reported revenue of ₹13.9 Lakh. Avyantra offers products and services including PreSCo and Periton Safe. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
The company a non-invasive machine learning platform to aid early risk assessment of neonatal Sepsis and treatment decisions, including antibiotic therapy. The company is also developing an automated peritoneal dialysis device in which the dialysate solution is inserted through the abdomen and performance parameters are monitored using IoT. The company has also developed non-invasive ventilation called Continuous Positive Airway Pressure (CPAP) product. It is the first-level respiratory therapy given to patients with respiratory distress.
- Headquarters Hyderabad, India
- Founders Hyma Goparaju, Kalluri Venkata Narasimha Rao
- SectorsHealthcare
- Website avyantra.com
- Social X
- Legal Name Avyantra Health Technologies Private Limited
- Date of Incorporation 26 Jul, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹13.9 Lakh
FY 2025 · +535% YoY
- Net Loss-₹30.1 Lakh
FY 2025 · -217% margin
- EBITDA-₹27.7 Lakh
FY 2025 · -200% margin
Associated legal entities of Avyantra
Avyantra operates through Avyantra Health Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avyantra Health Technologies Private Limited CIN U74999TG2017PTC118535 | Active | 26 Jul 2017 | Hyderabad, Telangana | ₹0.1 Cr | 2 | View details |
Products & Services of Avyantra
Avyantra offers a comprehensive portfolio of products and services, including PreSCo and Periton Safe.
Uses AI for early risk assessment of neonatal sepsis.
Provides IoT-enabled cost-effective peritoneal dialysis at home.
Board of directors of Avyantra Health Technologies Private Limited (Avyantra)
Avyantra Health Technologies Private Limited is the primary company behind Avyantra. The board of Avyantra Health Technologies Private Limited currently have 2 directors; the longest-serving is Narasimha Rao Kalluri, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Narasimha Rao Kalluri DIN 07857336 | Director | 26 Jul 2017 | 9 yrs 3 mo | Avyantra Health Technologies Private Limited |
| Hyma Goparaju DIN 00065801 | Director | 26 Jul 2017 | 9 yrs 3 mo | Avyantra Health Technologies Private Limited |
People of Avyantra
2 people are tracked at Avyantra (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Avyantra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Avyantra
Figures of Avyantra Health Technologies Private Limited, the primary company behind Avyantra, for FY 2025. Revenue was ₹13.9 Lakh (+535% year on year). Net loss was -₹30.1 Lakh (-217% margin). EBITDA was -₹27.7 Lakh (-200% margin). Revenue has grown at a compounded annual rate of +8% over three years and -22% over five years.
- ₹13.9 LakhRevenue · FY 2025 · +535% YoY
- -₹30.1 LakhNet loss · -217% margin
- -₹27.7 LakhEBITDA · -200% margin
- ₹1.1 LakhPaid-up capital
- +8%Revenue CAGR, 3 years
- -22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Avyantra Health Technologies Private Limited are on its company page.
Detailed financial statements for Avyantra
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avyantra
Complete news archive for Avyantra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avyantra
Avyantra was founded in 2017.
Avyantra is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Hyma Goparaju is the CEO of Avyantra, as recorded in our data. They have also founded this company.
The primary company behind Avyantra, Avyantra Health Technologies Private Limited, reported revenue of ₹13.9 Lakh for FY 2025, up 535% year on year.
The company a non-invasive machine learning platform to aid early risk assessment of neonatal Sepsis and treatment decisions, including antibiotic therapy. The company is also developing an automated peritoneal dialysis device in which the dialysate solution is inserted through the abdomen and performance parameters are monitored using IoT. The company has also developed non-invasive ventilation called Continuous Positive Airway Pressure (CPAP) product. It is the first-level respiratory therapy given to patients with respiratory distress.
Avyantra offers PreSCo and Periton Safe.
Avyantra operates through Avyantra Health Technologies Private Limited.
The legal entities of Avyantra currently have 2 directors, including Narasimha Rao Kalluri, Hyma Goparaju.